Logo

In The News

2022


April 28, 2022
WSJ

Biotech Venture Capital Investment in China Climbs

March 21, 2022
MedCity News

Precision oncology startup AnHeart Therapeutics co-founder shares cancer drug strategy

January, 10-12, 2022
Biotech Showcase

Outsmarting Cancer: Next Generation Therapies

2021


December 16, 2021
Bioworld

Anheart Therapeutics raises $61M in series B for precision oncology pipeline

December 14, 2021
Endpoints News

Lining up a filing for lead ROS1 inhibitor, transpacific oncology biotech AnHeart Therapeutics raises $61M

December 14, 2021
WSJ

AnHeart Takes Aim at Rare Mutation in Lung Cancer With $61 Million Financing

December 14, 2021
Biospace

With First Patients Dosed, AnHeart Snags $61 Million for Lung Cancer Hopeful

October 30, 2021
Targeted Oncology

Study of taletrectinib for ROS1 positive NSCLC Doses First Patient

October 26, 2021
Clinical Trials Arena

AnHeart Therapeutics begins dosing in Phase II lung cancer therapy trial

October 19, 2021
CURE Today

First Patient With NTRK Fusion-Positive Tumor Treated in Phase 2 Trial of Taletrectinib

September 28, 2021
OncLive

Taletrectinib Elicits Encouraging Responses in Crizotinib-Pretreated ROS1+ NSCLC

September 27, 2021
Cancer Network

Taletrectinib May Show Promise in ROS1+ Non–Small Cell Lung Cancer

September 27, 2021
European Pharmaceutical Review

Taletrectinib displays 90.5 percent objective response rate in NSCLC

  • About Us
    • Mission
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Investors
    • Contact
  • Pipeline
    • Overview
    • Taletrectinib AB-106
    • AB-218
    • AB-329
  • Publications
  • Clinical Trials
  • News
    • Press Releases
    • In the News
  • Careers
    • Values
    • Job Opportunities
  • Home
  • About Us
    • Mission
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Investors
    • Contact
  • Pipeline
    • Overview
    • Taletrectinib AB-106
    • AB-218
    • AB-329
  • Publications
  • Clinical Trials
  • News
    • Press Releases
    • In the News
  • Careers
    • Values
    • Job Opportunities
Logo

Contact Us

777 Third Avenue, Suite 1704
New York, NY 10017, USA
Tel: +1 212 466 6378

General Information:
info@anhearttherapeutics.com

Business Development:
bd@anhearttherapeutics.com

Twitter LinkedIn

  • Terms of Use
  • Privacy and Cookies Policy
© 2022 AnHeart Therapeutics All rights reserved.
Website Design: Hane Chow, Inc.